SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-074731
Filing Date
2012-11-06
Accepted
2012-11-06 16:16:00
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a12-20156_110q.htm 10-Q 1053663
2 EX-31.1 a12-20156_1ex31d1.htm EX-31.1 11929
3 EX-31.2 a12-20156_1ex31d2.htm EX-31.2 11932
4 EX-32.1 a12-20156_1ex32d1.htm EX-32.1 6160
5 EX-32.2 a12-20156_1ex32d2.htm EX-32.2 6259
  Complete submission text file 0001104659-12-074731.txt   8783855

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT irwd-20120930.xml EX-101.INS 1041325
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT irwd-20120930.xsd EX-101.SCH 100998
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT irwd-20120930_cal.xml EX-101.CAL 48096
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT irwd-20120930_lab.xml EX-101.LAB 1505944
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT irwd-20120930_pre.xml EX-101.PRE 746700
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT irwd-20120930_def.xml EX-101.DEF 538482
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176
Type: 10-Q | Act: 34 | File No.: 001-34620 | Film No.: 121183405
SIC: 2834 Pharmaceutical Preparations